Recombinant human YY1AP1   

HCCA1; HCCA2; Hepatocellular carcinoma susceptibility protein; Hepatocellular carcinoma-associated protein 2; YAP; YY1-associated protein 1; YY1AP; YYAP1_HUMAN.         

濃度：1mg/ ml

來(lái)源：Recombinant Human

純度：≥95% SDS-PAGE

表達(dá)系統(tǒng)：Escherichia coli

標(biāo)簽：His tag   

蛋白長(zhǎng)度：Full length protein

內(nèi)毒素水平：<1.000 Eu/µg

純化方法：HPLC

應(yīng)用：SDS-PAGE，Western blot，ELISA

Biological activity,immunology research

保存：-20℃

保質(zhì)期：1年

Enhances transcription activation by YY1. Tissue specificity:Ubiquitous. Detected in small intestine, skeletal muscle, lung, pancreas, brain, stomach, spleen, colon and heart. Detected at very low levels in healthy liver. Highly expressed in most liver carcinomas.

多克隆抗體

產(chǎn)品名稱：Rabbit Anti-YY1AP1 antibody

Rabbit Anti-YY1AP1 

別名：HCCA1; HCCA2; Hepatocellular carcinoma susceptibility protein; Hepatocellular carcinoma-associated protein 2; YAP; YY1-associated protein 1; YY1AP; YYAP1_HUMAN.                 

來(lái)源：Rabbit

克隆類型：Polyclonal

濃度：1mg/ml

亞型：IgG

反應(yīng)：Human

應(yīng)用： WB=1:1000-1:2000,Elisa=1:1000-1:2000,IHC-P=1:100-500,IHC-F=1:100-500,ICC/IF=1:100-500,IF=1:100-500

理論分子量：88kDa

免疫原：KLH conjugated synthetic peptide derived from human YY1AP1

保存：-20℃
保質(zhì)期：1年

 單克隆抗體

產(chǎn)品名稱：Anti-YY1AP1 antibody

Mouse Anti-YY1AP1

別名：HCCA1; HCCA2; Hepatocellular carcinoma susceptibility protein; Hepatocellular carcinoma-associated protein 2; YAP; YY1-associated protein 1; YY1AP; YYAP1_HUMAN.              

來(lái)源：Mouse

克隆類型：Monoclonal

濃度：1mg/ml

亞型：IgG

反應(yīng)：Human

應(yīng)用： WB=1:1000-1:2000,Elisa=1:1000-1:2000,IHC-P=1:100-500,IHC-F=1:100-500,ICC/IF=1:100-500,IF=1:100-500  

反應(yīng):  Human

理論分子量：88kDa

免疫原：KLH conjugated synthetic peptide derived from human YY1AP1

保存：-20℃
保質(zhì)期：1年

Enhances transcription activation by YY1. Tissue specificity:Ubiquitous. Detected in small intestine, skeletal muscle, lung, pancreas, brain, stomach, spleen, colon and heart. Detected at very low levels in healthy liver. Highly expressed in most liver carcinomas.